openPR Logo
Press release

The global drug API market is projected to grow during the forecast period 2018-2023

The global drug API market is projected to grow during

The recent study on the global drug API market covers an in-depth analysis of the market on the basis of drug synthesis type, application, and geography. The report also covers the country level analysis within the regions as well. Additionally, the report covers the key trends in the market along with drivers and restraints during the forecast period 2018-2023. According to the report titled “Global Drug API Market – Forecasts from 2018 to 2023”, the market is expected to increase from US$140.5 billion in 2017 to US$173.5 billion by 2023, at a CAGR of 3.58% during the projected period. The report has segmented the global drug API market by drug synthesis type (biotech drugs, synthetic drugs), application (generic drugs, branded drugs) and by geography (North America, South America, Europe, the Middle East and Africa, Asia Pacific). Active Pharmaceutical Ingredients, API is the active drug component which provides the required therapeutic effects as per the indication in a finished drug product. The growing market demand is due to the growing pharmaceutical industry due to the prevalence of chronic diseases, rising global geriatric population and rising healthcare expenditure among others. Furthermore, the growing popularity of the high potency active pharmaceutical ingredients will fuel the market growth in the coming years and beyond.

Request Sample: www.knowledge-sourcing.com/requestsample&sample_id=2243

Generic drug API is anticipated to grow at a CAGR of 6% during the forecast period.

The growth of generic drugs is mainly attributed to its availability to a wider number of populations having the absence of a significant difference in bioavailability between the two pharmaceutically equivalent products and are cheaper in comparison to the branded medicines. In addition, these medicines are manufactured under the same stringent standards in order to receive FDA approval as branded or innovator medicines.

The growing pharmaceutical industry is boosting the demand for drug API in the forecast period.

The pharmaceutical sector is expected to achieve a market size of around a trillion by 2020. The development and manufacturing of new and innovative drugs is driven by the worldwide prevalence of chronic diseases, rising incidences of cancers, rare diseases, changing lifestyle conditions and many more, which in turn is boosting the demand for drug APIs. Also, drug therapy has become an integral part of healthcare aiming towards revolutionizing the treatment of non-communicable diseases, further aiding the growth of the drug API market.

The Asia Pacific is the fastest growing market during the forecast period.

The Asia Pacific market is estimated to be the fastest growing with a CAGR of 4.20% in the forecast period of 2018-2023 where China and India are considered to be the fastest growing markets with a CAGR of 6.10% and 6.08% respectively. In the APAC region, China is the largest producer of generic API where the strength lies in the domestic market, while on the other hand, India relies mainly on export sales.
Some of the key players discussed in the reports are Teva Pharmaceutical Industries Limited, Dr. Reddy’s Laboratories Limited, and Cipla Inc., among others.

Request customization or place an order: www.knowledge-sourcing.com/global-drug-api-market

About Us:
Knowledge Sourcing Intelligence (KSI) is a market research and consulting organization based out of India. KSI publishes research studies spanning across ten industry verticals. KSI has a team of experienced and young professionals with a singular focus on delivering high-quality research services to enterprises, non-government organizations, government agencies, and research institutes and organizations. We publish hundreds of reports per year centering on niche and latest technologies. We engage with key decision makers and stakeholders across the value chain to provide clients with a detailed analysis and bird’s-eye view of the market with whole market dynamics, statistical forecasts, competitive analysis, key trends, market drivers and challenges and strategic recommendations for making informed decisions. Our success lies in the effort of our analysts who strive to meet client expectations by delivering quality work within the stipulated deadlines.

Contact:
Knowledge Sourcing Intelligence LLP
2nd Floor, D-77, Sector 63
Noida, U.P. - 201301
India
E: sales@knowledge-sourcing.com | P: +1-866-714-4587

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release The global drug API market is projected to grow during the forecast period 2018-2023 here

News-ID: 1624275 • Views: 266

More Releases from Knowledge Sourcing Intelligence LLP

Revenue Cycle Management Market Segmented by Product, Application, and Geography …
The recent study on the revenue cycle management market covers an in-depth analysis of the market on the basis of product, application, and geography. The report also covers the country level analysis within the regions as well. In addition, the report covers the key trends in the market along with drivers and restraints during the forecast period 2019-2024. According to the report titled “Revenue Cycle Management Market - Forecasts From
Automotive Catalyst Market Segmented by Type, Vehicle Type, and Geography (2019 …
The recent study on the automotive catalyst market covers in-depth analysis of the market on the basis of type, vehicle type, and geography. The report also covers the country level analysis within the regions as well. Additionally, the report covers the key trends in the market along with drivers and restraint during the forecast period 2019-2024. The report has segmented the automotive catalyst market by type (oxidation catalyst, three-way catalyst,
In-Memory Analytics Market Segmented by Component, deployment model, enterprise …
The report published by Knowledge Sourcing Intelligence titled “In-Memory Analytics Market- Forecast From 2019 to 2024” studies the various factors affecting the demand for In-Memory Analytics across the globe. The report has been segmented by component (software and services), by deployment model (On-premise and cloud), by enterprise size (small, medium, and large), by end-user industry (BFSI, retail, government, communication and technology, transportation and logistics, and others), and by geography, covering
Algae Oil Market Segmented by Grade, Application, and Geography (2018 to 2023)
The report published by Knowledge Sourcing Intelligence titled “Algae Oil Market- Forecast From 2018 to 2023” studies the various factors affecting the demand for algae oil across the globe. The report has been segmented by grade (food grade, feed grade, and fuel grade), by application (food and beverage, animal feed, biofuels, and dietary supplements), and by geography, covering five regions namely North America, South America, Europe, Middle East and Africa

All 429 Releases


More Releases for API

Tagraxofusp - API Insight, 2018
Tagraxofusp, sold under the brand name of Elzonris, is an Interleukin 3 (IL-3) conjugated truncated diphtheria toxin. It is composed of catalytic and translocation domains of diphtheria toxin fused via Met-His linker to a full-length human IL-3. Download the sample report @ https://www.pharmaproff.com/request-sample/1168 Tagraxofusp was developed by Stemline Therapeutics Inc. and was approved in December 2018, as the first therapy for blastic plasmacytoid dendritic cell neoplasm. This drug achieved approval after
Cabozantinib- API Insight, 2018
Cabozantinib, sold under the brand name of Cabometyx and Cometriq, is used for the treatment of medullary thyroid cancer and a second line treatment for renal cell carcinoma. It is a small molecule inhibitor of the tyrosine kinases c-Met and VEGFR2, and also inhibits AXL and RET. Download the sample report @ https://www.pharmaproff.com/request-sample/1164 Discovered and developed by Exelixis Inc., its side-effects include increased liver enzymes, diarrhea, low calcium, mouth sores, decreased
Tyk API Management v2.3
After months working-out in the gym, the new version of Tyk is ready to flex its muscles.   Tyk v2.3 is twice as fast, leaner, more extendable and is still available for FREE! London, United Kingdom 8th December, 2016. Tyk Technologies is pleased to announce the v2.3 release of Tyk, the popular open-source API Management platform.   Tyk v2.3 builds upon the success of previous releases. The feedback and contributions from Tyk’s thriving open source community, as well as enterprise clients, drove
Telecom API Helps Application Developers to Integrate Various API Services
Telecom API market represents an overall Application Programming Interface (API) services provided by telecom carriers, service providers and aggregators to application developers in order to create mobile applications. Telecom API helps application developers to integrate various services such as payment, voice, SMS and WebRTC into their mobile application. This helps application developers to enhance their customer experience and market their mobile applications among end-users. Telecom API provides many benefits to
Biotech API Surging Worldwide
According to a new research report by RNCOS, entitled “Global Biotech API Market Analysis”, geographies across the world are showing insurgent growth in the biotech API Industry. The US occupied more than half of the share in the global market in 2011, and is the largest producer of biotech APIs. Western European countries occupy around 15% share globally among which, the UK is the largest producer of biotechnology-based APIs. The
Global Biotech API Market Analysis
RNCOS has recently added a new Market Research Report titled, “Global Biotech API Market Analysis” to its report gallery. Biotech APIs contribute a very low share in the global API market with synthetic API’s accounting for majority of the formulations. However, with the revolutionary growth in the biopharmaceutical industry and gaining applications of biotech drugs, biotech API’s are sure to see a highly prospective market in the future. As per our